Androgen News and Research

RSS

Calcium intake could be used as a prognostic factor for osteoporosis

Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.

11 Apr 2007

Research shows relationship between low calcium intake and higher levels of osteoporosis in men with prostate cancer

Daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.

11 Apr 2007

Curry related compound shows promise against Kennedy's disease

Scientists who focus on the molecular signaling that underlies prostate cancer have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene.

21 Mar 2007

Obesity at the time of prostate-cancer diagnosis dramatically increases the risk of dying from the disease

Obese men who are diagnosed with prostate cancer have more than two-and-a-half times the risk of dying from the disease as compared to men of normal weight at the time of diagnosis, according to a study by researchers at Fred Hutchinson Cancer Research Center.

15 Mar 2007

Androgen deprivation therapy may increase risk of death from heart disease in older men

Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.

26 Feb 2007

Spearmint tea - natural treatment for hirsutism

Turkish researchers say women who suffer from excessive hair growth (hirsutism) may be helped by drinking spearmint tea.

21 Feb 2007

Hirsute women may benefit from spearmint tea

Women with hirsutism grow hair on their faces, breasts and stomachs. This can cause great distress.

20 Feb 2007

Tea tree and lavender oils may cause enlarged breasts in boys

According to new research the use of shampoos, soaps and lotions which contain lavender oil and tea tree oils can cause some boys to develop enlarged breasts.

1 Feb 2007

Testosterone replacement therapy appears to be safe - has little effect on the prostate gland

Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.

14 Nov 2006

Scientists discover how androgen plays a role in the development of prostate cancer

Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer.

8 Nov 2006

New research could affect future treatment options for prostate cancer

Two new studies on the treatment of prostate cancer could well affect future treatment options for patients.

8 Nov 2006

Overweight women more likely to have polycystic ovary syndrome

Overweight and obese Spanish women appear five times as likely as lean women to have polycystic ovary syndrome, a condition that decreases fertility and contributes to other illnesses, according to an article in the October 23 issue of Archives of Internal Medicine.

23 Oct 2006

Long-term oncologic outcomes: A 40 year radical prostatectomy single institution series

Single institution long-term outcomes for radical prostatectomy are scarce in the literature. In the August 2006 issue of the Journal of Urology, Dr. Porter from the Virginia Mason Medical Center, Seattle, WA reports on 25-year cancer outcomes for radical prostatectomy (RP).

6 Sep 2006

Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor

A new study appearing in the September issue of the Journal of Clinical Investigation indicates that caution might be needed if a new group of drugs known as estrens are to be developed for the treatment of osteoporosis.

4 Sep 2006

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

The National Women's Health Network has petitioned FDA to stop sales of Solvay's Estratest and Breckenridge Pharmaceuticals' Syntest, which are estrogen-testosterone combination therapies used to treat menopause-associated hot flashes, until they are proven safe and effective, Reuters reports.

24 Aug 2006

Androgen News and Research

Calcium intake could be used as a prognostic factor for osteoporosis

Research shows relationship between low calcium intake and higher levels of osteoporosis in men with prostate cancer

Curry related compound shows promise against Kennedy's disease

Obesity at the time of prostate-cancer diagnosis dramatically increases the risk of dying from the disease

Androgen deprivation therapy may increase risk of death from heart disease in older men

Spearmint tea - natural treatment for hirsutism

Hirsute women may benefit from spearmint tea

Tea tree and lavender oils may cause enlarged breasts in boys

Testosterone replacement therapy appears to be safe - has little effect on the prostate gland

Scientists discover how androgen plays a role in the development of prostate cancer

New research could affect future treatment options for prostate cancer

Overweight women more likely to have polycystic ovary syndrome

Long-term oncologic outcomes: A 40 year radical prostatectomy single institution series

Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

Variances in patterns of care for patients with prostate cancer failing primary therapy

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Biomira Stimuvax prostate cancer study results published

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News